VPRO — Viropro Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.03m
- $11.96m
- $0.57m
Annual income statement for Viropro, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 November 30th | 2008 November 30th | 2009 November 30th | 2010 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.264 | 0 | 0 | 0.571 |
| Cost of Revenue | ||||
| Gross Profit | 0.264 | 0 | 0 | — |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 2.04 | 1.25 | 1.08 | 1.57 |
| Operating Profit | -1.78 | -1.25 | -1.08 | -0.997 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -2.65 | -1.74 | -1.46 | -1.01 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -2.65 | -1.74 | -1.46 | -1.01 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -2.65 | -1.74 | -1.46 | -1.01 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -2.65 | -1.74 | -1.46 | -1.01 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.075 | -0.036 | -0.012 | -0.004 |
| Dividends per Share |